HALT MBC: HER2 suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LPT112515)

被引：0

作者：

Lin, Nancy U.

Danso, Michael A.

David, Alice K.

Muscato, Joseph J.

Rayson, Daniel

Houck, William A.

Ellis, Catherine Elizabeth

DeSilvio, Michelle

Garofalo, Amanda

Nagarwala, Yasir M.

Winer, Eric

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Virginia Oncol Associates, Norfolk, VA USA

[3] Augusta Oncol Associates, Augusta, GA USA

[4] Missouri Canc Associates, Columbia, MO USA

[5] QEII Hlth Sci Ctr, Halifax, NS, Canada

[6] Virginia Canc Specialists PC, Winchester, VA USA

[7] GlaxoSmithKline Oncol, Collegeville, PA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS658

引用

页数：1